Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > It is frustrating...

<< Previous

Bullboard Posts

Next >>

Comment by Kswdeluxon Nov 15, 2022 1:49pm

132 Views

Post# 35100654

RE:RE:RE:It is frustrating...

jimsenior wrote: I think you will find the poster under technology - website.

I do agree about who applies, but we do not know where we are in any discussions,

I agree also in re the tone. MC was hard to read; either desperation or I have a done deal. let us get out of here.

Buyout and soon is best for all. Cheers

I guess I missed that, but did not hear any discussion, so assumed it was not issued. It was a nothing event as well then. Thanks for pointing that out.

Cheers !

<< Previous

Bullboard Posts

Next >>

From now on, dynaCERT instead of Bitcoin or NVIDIA?